cefuroksiini

Cefuroksiini is a second-generation cephalosporin antibiotic used to treat a variety of bacterial infections. It works by inhibiting the synthesis of the bacterial cell wall, which leads to bacterial death. Cefuroksiini is effective against a range of Gram-positive and Gram-negative bacteria, including many that are resistant to earlier generation cephalosporins.

It is commonly prescribed for respiratory tract infections such as pneumonia and bronchitis, urinary tract infections, skin and soft tissue infections, and Lyme disease. Cefuroksiini is available in both oral and injectable forms. The oral form, cefuroxime axetil, is a prodrug that is converted to the active form, cefuroxime, in the body. The injectable form is administered directly as cefuroxime sodium.

Common side effects of cefuroksiini include nausea, vomiting, diarrhea, and headache. Allergic reactions, though rare, can occur. As with all antibiotics, overuse or misuse of cefuroksiini can contribute to the development of antibiotic resistance. It is important to take the medication exactly as prescribed by a healthcare professional and to complete the full course of treatment, even if symptoms improve. Cefuroksiini should be used with caution in individuals with a history of penicillin allergy, as cross-reactivity can occur.